Left ventricular assist devices: yesterday, today, and tomorrow.

Autor: Tsiouris A; Department of Surgery, Division of Cardiac Surgery, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA. athtsiouris@hotmail.com., Slaughter MS; Department of Cardiovascular and Thoracic Surgery, University of Louisville, 201 Abraham Flexner Way, Louisville, KY, 40202, USA., Jeyakumar AKC; Department of Surgery, Division of Cardiac Surgery, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA., Protos AN; Department of Surgery, Division of Cardiac Surgery, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
Jazyk: angličtina
Zdroj: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs [J Artif Organs] 2024 Dec; Vol. 27 (4), pp. 335-344. Date of Electronic Publication: 2024 Mar 07.
DOI: 10.1007/s10047-024-01436-0
Abstrakt: The shortcomings of expense, power requirements, infection, durability, size, and blood trauma of current durable LVADs have been recognized for many years. The LVADs of tomorrow aspire to be fully implantable, durable, mitigate infectious risk, mimic the pulsatile nature of the native cardiac cycle, as well as minimize bleeding and thrombosis. Power draw, battery cycle lifespan and trans-cutaneous energy transmission remain barriers to completely implantable systems. Potential solutions include decreases in pump electrical draw, improving battery lifecycle technology and better trans-cutaneous energy transmission, potentially from Free-range Resonant Electrical Energy Delivery. In this review, we briefly discuss the history of LVADs and summarize the LVAD devices in the development pipeline seeking to address these issues.
Competing Interests: Declarations. Conflicts of interest: None to disclose.
(© 2024. The Japanese Society for Artificial Organs.)
Databáze: MEDLINE